Literature DB >> 8625628

Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial.

C D Spies1, N Dubisz, T Neumann, S Blum, C Müller, H Rommelspacher, G Brummer, M Specht, C Sanft, L Hannemann, H W Striebel, W Schaffartzik.   

Abstract

OBJECTIVES: To assess the effect of three different alcohol withdrawal therapy regimens in traumatized chronic alcoholic patients with respect to the duration of mechanical ventilation and the frequency of pneumonia and cardiac disorders during their intensive care unit (ICU) stay.
DESIGN: A prospective, randomized, blinded, controlled clinical trial.
SETTING: A university hospital ICU. PATIENTS: Multiple-injured alcohol-dependent patients (n=180) transferred to the ICU after admission to the emergency room and operative management. A total of 180 patients were included in the study; however, 21 patients were excluded from the study after assignment.
INTERVENTIONS: Patients who developed actual alcohol withdrawal syndrome were randomized to one of the following treatment regimens: flunitrazepam/clonidine (n=54); chlormethiazole/haloperidol (n=50); or flunitrazepam/haloperidol (n=55). The need for administration of medication was determined, using a validated measure of the severity of alcohol withdrawal (Revised Clinical Institute Withdrawal Assessment for Alcohol Scale).
MEASUREMENTS AND MAIN RESULTS: The duration of mechanical ventilation and major intercurrent complications, such as pneumonia, sepsis, cardiac disorders, bleeding disorders, and death, were documented. Patients did not differ significantly between groups regarding age, Revised Trauma and Injury Severity Score and Acute Physiology and Chronic Health Evaluation II score on admission. In all except four patients in the flunitrazepam/clonidine group, who continued to hallucinate, the Revised Clinical Institute Withdrawal Assessment for Alcohol Scale decreased to <20 after initiation of therapy. ICU stay did not significantly differ between groups (p=.1669). However, mechanical ventilation was significantly prolonged in the chlormethiazole/haloperidol group (p=.0315) due to an increased frequency of pneumonia (p=.0414). Cardiac complications were significantly (p=.0047) increased in the flunitrazepam/clonidine group.
CONCLUSIONS: There was some advantage in the flunitrazepam/clonidine regimen with respect to pneumonia and the necessity for mechanical ventilation. However, four (7%) patients had to be excluded from the study due to ongoing hallucinations during therapy. Also, cardiac complications were increased in this group. Thus, flunitrazepam/haloperidol should be preferred in patients with cardiac or pulmonary risk. Further studies are required to determine which therapy should be considered.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625628     DOI: 10.1097/00003246-199603000-00009

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  30 in total

Review 1.  Alcohol-use disorders in the critically ill patient.

Authors:  Marjolein de Wit; Drew G Jones; Curtis N Sessler; Marya D Zilberberg; Michael F Weaver
Journal:  Chest       Date:  2010-10       Impact factor: 9.410

2.  Validity and reliability of the DDS for severity of delirium in the ICU.

Authors:  Hilke Otter; Jörg Martin; Katrin Bäsell; Christian von Heymann; Ortrud Vargas Hein; Patricia Böllert; Pattariya Jänsch; Ina Behnisch; Klaus-Dieter Wernecke; Wolfgang Konertz; Stefan Loening; Jens-Uwe Blohmer; Claudia Spies
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens.

Authors:  Jeffrey A Gold; Binaya Rimal; Anna Nolan; Lewis S Nelson
Journal:  Crit Care Med       Date:  2007-03       Impact factor: 7.598

4.  Use of α(2)-Agonists in Neuroanesthesia: An Overview.

Authors:  Ehab Farag; Maged Argalious; Daniel I Sessler; Andrea Kurz; Zeyd Y Ebrahim; Armin Schubert
Journal:  Ochsner J       Date:  2011

Review 5.  Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

Authors:  Timothy E Albertson; James Chenoweth; Jonathan Ford; Kelly Owen; Mark E Sutter
Journal:  J Med Toxicol       Date:  2014-12

6.  Prevalence and Variation of Clinically Recognized Inpatient Alcohol Withdrawal Syndrome in the Veterans Health Administration.

Authors:  Tessa L Steel; Carol A Malte; Katharine A Bradley; Sharukh Lokhandwala; Catherine L Hough; Eric J Hawkins
Journal:  J Addict Med       Date:  2020 Jul/Aug       Impact factor: 3.702

Review 7.  Alcoholism and critical illness: A review.

Authors:  Ashish Jitendra Mehta
Journal:  World J Crit Care Med       Date:  2016-02-04

Review 8.  Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management.

Authors:  Matti Hillbom; Ilkka Pieninkeroinen; Maurizio Leone
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  Respiratory, metabolic and hemodynamic effects of clonidine in ventilated patients presenting with withdrawal syndrome.

Authors:  Domniki Liatsi; Basilis Tsapas; Smaro Pampori; Matthew Tsagourias; Ioannis Pneumatikos; Dimitrios Matamis
Journal:  Intensive Care Med       Date:  2008-08-16       Impact factor: 17.440

Review 10.  [The alcoholic patient in the daily routine].

Authors:  Jan-Philipp Breuer; Tim Neumann; Andreas Heinz; Wolfgang J Kox; Claudia Spies
Journal:  Wien Klin Wochenschr       Date:  2003-09-30       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.